A successful cord blood transplant in a child with second accelerated phase chronic myeloid leukemia following lymphoid blast crisis

Bone Marrow Transplantation

Volumn 25, Issue 2, 2000, Pages 213-215

  Maschan, A A ^a,b   Skorobogatova, E V ^a   Samotchatova, E V ^a   Balashov, D N ^a   Yourlova, M I ^a   Bogatcheva, N I ^a   Pashanov, E D ^a   Trakhtman, P E ^a   Timakov, A M ^a   Rumiantzev, A G ^a  

^a Russian Children's Hospital   (Russian Federation)

^b Research Institute of Pediatric Hematology   (Russian Federation)

Author keywords

Blast crisis; Chronic myeloid leukemia; Cord blood transplantation; GVL effect

Indexed keywords

ALPHA2B INTERFERON; AMOXICILLIN; AMPHOTERICIN B; ASPARAGINASE; BUSULFAN; CD34 ANTIGEN; CIPROFLOXACIN; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FLUCONAZOLE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; PREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON; TIOGUANINE; VINCRISTINE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLAST CELL CRISIS; CANCER CHEMOTHERAPY; CASE REPORT; CHIMERA; CHRONIC MYELOID LEUKEMIA; COLONY FORMING UNIT GM; CRYOPRESERVATION; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; INFECTION; PHILADELPHIA 1 CHROMOSOME; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RNA ANALYSIS; UMBILICAL CORD BLOOD;

EID: 0033973644     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702105     Document Type: Article

References (9)

1. Munoz A, Bureo E, Ortega JJ et al. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic hone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON) Haematologica 1998; 83: 981-984.
2. Creutzig U, Ritter J, Zimmermann M, Klingebiel T. Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients. Klin Padiatr 1996; 208: 236-241.
3. Beatty PG, Mori M, Milford E. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation 1995; 60: 778-783.
4. Schrappe M, Reiter A, Sauter S et al. Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow. Klin Padiatr 1994; 206: 208-221.
5. Rivera GK, Hudson MM, Liu Q et al. Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia. Blood 1996; 88: 831-837.
6. Gratwohl A, Hermans J, Goldman JM et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 1998; 352; 1087-1092.
7. Keever CA. Characterization of cord blood lymphocyte sub-populations. J Hematother 1993; 2: 203-206.
8. Collins RH Jr, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444.
9. Brandenburg U, Gottlieb D, Bradstock K. Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Leuk Lymphoma 1998; 31: 545-550.